[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 4th Pharmaceuticals Subcommittee Meeting
Press Release
(Joint Meeting with Bio-products Subcommittee)
Date and Time: May 10, 2013 from 6pm to 8pm
Agenda / List of Handouts
Agenda
- Personalized medicine
- (1) Direction and method of future discussion
- (2) Scope and positioning of biomarker endpoint
- Others
List of Handouts
- Document 1 Direction and method of discussion in the joint meeting of the Pharmaceuticals and Bio-products Subcommittees (draft)
- Document 2 Biomarker
- Document 3 Using biomarker in pharmaceutical development
- Ref. Examples of biomarkers used for clinical evaluation (therapeutic medicine for osteoporosis)